Post-market surveillance for reimbursed devices in Japan requires manufacturers to monitor safety, efficacy, & performance. They must report adverse events, submit periodic safety updates, & conduct post-marketing studies if mandated. Compliance with PMDA & MHLW regulations ensures devices maintain their approved reimbursement status under the NHI system while safeguarding public health.
